PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Drug-eluting stents: An overview PART 06: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 07: Drugs employed in drug-eluting stents PART 08: Geographical segmentation • Drug-eluting stent market in Americas • Drug-eluting stent market in EMEA • Drug-eluting stent market in APAC PART 09: Key leading countries • US • China • Germany • Japan PART 10: Market drivers • High prevalence of atherosclerosis diseases • Favorable reimbursement scenario • Reduced risk of contracting restenosis • Technological advancements PART 11: Impact of drivers PART 12: Market challenges • Decline in price of drug-eluting stents • Availability of alternative procedures • Preference for drugs over stents • Risk of late-stage thrombosis PART 13: Impact of drivers and challenges PART 14: Market trends • Increasing partnership and collaboration activities • Growing popularity of hybrid procedures • Growing focus on emerging countries PART 15: Vendor landscape • Competitive scenario • Market share analysis 2015 • Key vendor analysis • Abbott Laboratories • Biosensors International • Boston Scientific • Medtronic • Terumo • Other prominent vendors PART 16: Appendix • List of abbreviations PART 17: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Treatment options: Percutaneous coronary intervention Exhibit 03: Cross section of a stent Exhibit 04: Agents used in drug-eluting stents Exhibit 05: History of drug-eluting stent Exhibit 06: Global drug-eluting stent market 2015-2020 ($ billions) Exhibit 07: Five forces analysis Exhibit 08: Classification of drugs used in drug-eluting stents Exhibit 09: Segmentation of global drug-eluting stent market by geography 2015 Exhibit 10: Segmentation of global drug-eluting stent market by geography 2020 Exhibit 11: Segmentation of global drug-eluting stent market by geography 2015-2020 Exhibit 12: Drug-eluting stent market in Americas 2015-2020 ($ billions) Exhibit 13: Drug-eluting stent market in EMEA 2015-2020 ($ billions) Exhibit 14: Drug-eluting stent market in APAC 2015-2020 ($ billions) Exhibit 15: Key leading countries Exhibit 16: Market share of key leading countries in global drug-eluting stent market 2015 Exhibit 17: List of major biodegradable-coated drug-eluting stent products 2015 Exhibit 18: Impact of drivers Exhibit 19: Impact of drivers and challenges Exhibit 20: Estimated healthcare spending in BRIC countries in 2015 ($ billions) Exhibit 21: Abbott Laboratories: Key takeaways Exhibit 22: Biosensors International: Business segmentation by revenue 2015 Exhibit 23: Biosensors International: Key takeaways Exhibit 24: Boston Scientific: Business segmentation by revenue 2014 Exhibit 25: Boston Scientific: Geographical segmentation by revenue 2014 Exhibit 26: Boston Scientific: Key takeaways Exhibit 27: Medtronic: Key takeaways Exhibit 28: Terumo: Key takeaways

Abbott Laboratories, Biosensors International Group, Boston Scientific, Medtronic, Terumo Corporation, Biotronik, Cook Medical, Envision Scientific, Lepu Medical, Meril Life Sciences, MicroPort Medical, Opto Circuits, Shandong JW Medical Systems, STENTYS.